Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7152)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lim SM, Lim JY, Cho JY. Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome. World J Gastroenterol 2014; 20(8): 2042-2050 [PMID: 24587678 DOI: 10.3748/wjg.v20.i8.2042] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i8/2042.htm |
| Number | Citing Articles |
| 1 |
Junhao Fang, Qi Chen, Guoyu Wu. Genomics-based tools for drug discovery and development: From network maps to efficacy prediction. Journal of Holistic Integrative Pharmacy 2023; 4(3): 199 doi: 10.1016/j.jhip.2023.11.001
|
| 2 |
Xiao-San Zhu, Peng Gao, Yi-Chen Dai, Jun-Pei Xie, Wei Zeng, Qing-Na Lian. Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro. Cellular and Molecular Biology Letters 2014; 19(4) doi: 10.2478/s11658-014-0213-5
|
| 3 |
Ruzhen Chen, Xun Wang, Xinru Deng, Lanhui Chen, Zhongyang Liu, Dong Li. CPDR: An R Package of Recommending Personalized Drugs for Cancer Patients by Reversing the Individual’s Disease-Related Signature. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.904909
|
| 4 |
Yuqin Lin, Yanghong Zhu, Xiang Li, Qi Chen, Guoyu Wu. Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer. Journal of Holistic Integrative Pharmacy 2023; 4(4): 318 doi: 10.1016/j.jhip.2023.12.001
|
| 5 |
Horst Flotow. The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer. Future Medicinal Chemistry 2014; 6(18): 2103 doi: 10.4155/fmc.14.131
|
| 6 |
Likun Jiang, Susu Qu, Zhengqiu Yu, Jianmin Wang, Xiangrong Liu. MOASL: Predicting drug mechanism of actions through similarity learning with transcriptomic signature. Computers in Biology and Medicine 2024; 169: 107853 doi: 10.1016/j.compbiomed.2023.107853
|
| 7 |
Xuefen Lei, Feng Wang, Yang Ke, Dong Wei, Hou Gu, Zhixian Zhang, Lifeng Jiang, Li Lv, Jie Lin, Lin Wang. The role of antiangiogenic agents in the treatment of gastric cancer. Medicine 2017; 96(10): e6301 doi: 10.1097/MD.0000000000006301
|
| 8 |
Wenyan Wang, Hui Wang, Yingying Ni, Zhenming Yao, Liang Ye, Jingwei Tian. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models. Tumor Biology 2016; 37(7): 9221 doi: 10.1007/s13277-016-4826-3
|
| 9 |
Jianling Xia, Hongqiang Wang, Shi Li, Qinghui Wu, Li Sun, Hongxiang Huang, Ming Zeng. Ion channels or aquaporins as novel molecular targets in gastric cancer. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0622-y
|
| 10 |
Fuyou Zhang, Jianfa Li, Huizhong Xiao, Yifan Zou, Yuchen Liu, Weiren Huang. AFAP1‐AS1: A novel oncogenic long non‐coding RNA in human cancers. Cell Proliferation 2018; 51(1) doi: 10.1111/cpr.12397
|
| 11 |
Enrique Bellolio, Ismael Riquelme, Angela L. Riffo-Campos, Carlos Rueda, Catterina Ferreccio, Miguel Villaseca, Priscilla Brebi, Sergio Muñoz, Juan Carlos Araya. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System. Pathology & Oncology Research 2019; 25(3): 1135 doi: 10.1007/s12253-018-0532-3
|
| 12 |
Aliyu Musa, Laleh Soltan Ghoraie, Shu-Dong Zhang, Galina Galzko, Olli Yli-Harja, Matthias Dehmer, Benjamin Haibe-Kains, Frank Emmert-Streib. A review of connectivity map and computational approaches in pharmacogenomics. Briefings in Bioinformatics 2017; : bbw112 doi: 10.1093/bib/bbw112
|
| 13 |
Ji Xue, Ying Li, Jianfeng Yi, Hong Jiang. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/6746970
|
| 14 |
Shan-Ju Yeh, Chien-Yu Lin, Cheng-Wei Li, Bor-Sen Chen. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer. International Journal of Molecular Sciences 2019; 20(10): 2536 doi: 10.3390/ijms20102536
|
| 15 |
Chunchao Zhu, Jia Xu, Maoran Li, Gang Zhao, Hui Cao. Heterogeneity of c-Met expression in Chinese gastric cancer patients. Human Pathology 2015; 46(12): 1901 doi: 10.1016/j.humpath.2015.06.025
|
| 16 |
Jianfa Li, Yincong Chen, Zhicong Chen, Anbang He, Haibiao Xie, Qiaoxiao Zhang, Zhiming Cai, Yuchen Liu, Weiren Huang. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers. Tumor Biology 2017; 39(6): 101042831771140 doi: 10.1177/1010428317711406
|
| 17 |
Yongfu Shao, Huilin Chen, Xiaoming Jiang, Shengcan Chen, Peifei Li, Meng Ye, Qier Li, Weiliang Sun, Junming Guo. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumor Biology 2014; 35(10): 9591 doi: 10.1007/s13277-014-2243-z
|
| 18 |
Nevin Tham, Sarah R. Langley. Evaluating the robustness of connectivity methods to noise for in silico drug repurposing studies. Frontiers in Systems Biology 2022; 2 doi: 10.3389/fsysb.2022.1050730
|